MedPath

Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study

Recruiting
Conditions
Alcohol Drinking
Alcohol Use Disorder
Alcohol Intoxication
Alcohol; Harmful Use
Alcoholism
Binge Drinking
Registration Number
NCT06687525
Lead Sponsor
University of Illinois at Urbana-Champaign
Brief Summary

In this study, the investigators aim to capture inter- and intra-brain mechanisms underlying alcohol reward in novel social context.

Detailed Description

Objective: Alcohol's ability to boost mood in the face of stress is perhaps its most notoriously addictive property, long held by researchers to be of critical importance for understanding alcohol use disorder (AUD) etiology. Yet, while most real-world alcohol consumption occurs in social settings, in the context of laboratory studies, participants have almost always consumed alcohol alone. The discrepancy between real-world and laboratory contexts emerges as particularly stark in the neuroimaging literature, where no alcohol-administration study to date has incorporated in-vivo social context. In this first alcohol-administration study to leverage EEG hyperscanning methods, the investigators aim to capture inter- and intra-brain mechanisms underlying alcohol reward in novel social context.

Specifically, this study aims to characterize the mechanisms driving social reward from alcohol in the context of stress and elucidate the role of social processes and novel social context in driving problem drinking.

Study Population: Participants will consist of 240 regular drinkers, aged 21-30, with no reported history of severe alcohol use disorder.

Design: In the laboratory arm of the study, individuals will be randomly assigned to consume either a moderate dose of alcohol or a control beverage in stranger dyads. Participants will engage in both structured and unstructured tasks aimed at assessing social engagement and threat sensitivity. EEG and ERP data will be collected from both participants simultaneously. In the ambulatory study arm, participants will wear transdermal sensors to assess BAC and will further provide information about their mood and their social contexts in response to random prompts.

Outcome Measures: Primary outcome measures include EEG measures of inter-brain entrainment as well as ERP metrics derived from task contexts (both players and observers). Additional outcomes include measures of positive mood, negative mood, and social bonding. Finally, drinking behaviors will be assessed via transdermal ambulatory alcohol sensors and longitudinal self-reports of drinking.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
240
Inclusion Criteria
  • Between the ages of 21 and 30
  • Regularly consumes alcohol
Exclusion Criteria
  • History of adverse reaction to the amount of beverage employed in the study
  • Have a history of major problems associated with alcohol
  • Take medications that could adversely interact with alcohol
  • Have medical conditions that contraindicate alcohol administration
  • Individuals with a history of skull fractures or who indicate discomfort with EEG procedures used
  • Female participant is pregnant or trying to become pregnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Inter-brain entrainmentDuring active laboratory beverage manipulation exposure (during or immediately after beverage administration, at which time participants in the alcohol condition will register a positive BAC)

The association between dyad-members EEG signals during the hyperscanning task

Feedback-related negativityDuring active laboratory beverage manipulation exposure (during or immediately after beverage administration, at which time participants in the alcohol condition will register a positive BAC)

An ERP component calculated from a time-estimation task

Ambulatory Drinking14 days

Drinking behavior assessed outside the laboratory using ambulatory assessment

Longitudinal Drinking ProblemsUp to 24 months post-baseline

Drinking assessed at longitudinal follow-up

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Illinois at Urbana-Champaign

🇺🇸

Champaign, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath